Summit Therapeutics (SMMT) stock valuation

$10.51 Nov 18, 2026 · market cap $7.9B

7/121 investors
i

Summit Therapeutics trades at $11. We don't have a valuation for it yet.

7 of 121 tracked investors hold it · Q3 2026 13F filings

Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app

5 AI analysts debate SMMTCreate free account →

Full open-source research report for SMMT on DeepValues Research (CC BY 4.0)